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(p value¼0.05). On bleeding academic research consortium (BARC)
scale, type 1 and 2 bleeding were higher with eptifibatide (OR, 3.18;
95% CI, 1.76-5.74; p value¼ 0.0001), however the more serious
(composite of type 3 and 5) bleeds did not differ between the two
groups (OR, 1.73; 95% CI, 0.7-4.08; p value¼ 0.21).
Conclusion: Patients with postinfarction angina, unwilling for
intervention, had reduced incidence of recurrent angina and
earlier relief of anginal symptoms, when eptifibatide was added to
intensified antianginal therapy. This, it achieved without causing
significant difference in the primary composite end points.
Although significant increase was noted in types 1 and 2 BARC
bleeding in the group A, incidence of higher degree bleeds did not
differ significantly between the two groups.
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Background: Mortality of STEMI even in the current coronary
intervention era is 7-8%. The relationship between pre infarction
angina (PIA) and mortality has been studied in the past. However
factors that determine favorable outcome in preinfarction angina
have not been studied in our population. In this context, this study
has been done to evaluate the relationship between preinfarction
angina and its beneficial effect in STEMI outcome.
Aim: To evaluate outcome of pre infarction angina in STEMI pa-
tients, related to CK-MB level, baseline
LV function on admission and in-hospital outcome and
mortality.
Methods: Non Randomized Observational (Prospective Study)
Study Period e July (1-31) 2014.
STEMI Patients Admitted In CCU
Inclusion criteria: 1. All AWMI as a first ACS event (acute or
recent not old) irrespective of comorbid conditions and risk fac-
tors 2. All AWMI lysed (or) treated by conservative management
Results: Total no of patients observed n¼29. Out of these PIA
present in 10 patients. PIA absent in 19 patients. CK-MB median
level after admission was lower in PIA positive group. Baseline LV
function was also better in PIA postive group (median EF ¼ 45%).
Complications like Arrythmia, Cardiogenic shock and freewall
rupture were absent in pia positive group. Mortality was also nil
PIA positive group.
Conclusion: Presence of preinfarction angina in anterior STEMI is
associated with lower in-hospital mortality, better LV-function
and preserves electrical stability in our population.
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Objective: This study was undertaken to correlate the magnitude
of T inversion following thrombolysis in acute STEMI with Infarct
Related Artery (IRA) patency.
Background: Although many studies have demonstrated the as-
sociation between early T wave inversion after thrombolysis and
angiographic patency, T wave inversion magnitude after suc-
cessful lysis with resolved ST segment was further evaluated in
relation to IRA patency.
Methods: This is a prospective observational study done during
the month of April 2014 in tertiary care hospital. A total of twenty
patients, age ranging from 32 to 60 yrs with anterior and inferior
wall STEMI who were treated with I.V streptokinase as per pro-
tocol on admission and predischarge coronary angiogram was
done within 5 days of admission . Patient stratification was done
based on the depth and width of maximally inverted negative T
waves, ejection fraction and it was correlated with angiographic
patency of IRA.
Results: Among the twenty patients, recanalised IRA was found in
2 patients who had more broad and deeply inverted T waves in
ECG. In the remaining 18 patients, deeper inverted T waves in 12
patients was associated with better patency rate of IRA(70% vs
30%), lower peak CPK value (250+/_50 vs 400+/-100) better EF (50+/
_10% vs 35+/_5%) than the 6 patients who had small inverted T
waves .
Conclusion: Early T wave inversion as quoted earlier has good
correlation with IRA patency. Also some correlation was found
between quantum of T wave inversion with IRA patency. How-
ever, this was not linear and further studies are required.
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Background: The optimal reperfusion strategy in very elderly pa-
tients (age >80years) with STEMI still remains a topic of debate.
This may largely be attributed to omission / under-representation
of the very elderly in clinical trials. Tailored thrombolytic therapy
(TLT) may be an appropriate option for such selected individuals,
even in this era of primary PCI. Here, we present our single-unit
experience in tailored thrombolysis for very elderly over the last 5
years.
Materials and Methods: We did 8 cases of reperfusion therapy in
the very elderly over the last 5 years. There were 5 males and 3
females and were in the age group of 80 e 90 years. 5 patients
presented with acute IWMI and 3 patients with acute AWMI. 3
patients had creatinine levels > 2 mg/dl. 3 patients were under-
weight (<50 kg), 2 patients had COPD and 2 patients had gastritis.
The options of primary PCI and thrombolytic therapy were dis-
cussed; after which, 3 patients opted for primary PCI and stenting.
The remaining 5 patients were discussed regarding conventional
thrombolysis & tailored thrombolysis (TLT), and the higher risk of
bleeding with conventional thrombolysis. They were then taken
up for tailored thrombolytic therapy. The regimen included an
initial IV Tenecteplase 0.25 mg/Kg (half-dose Tenecteplase) fol-
lowed by assessment for resolution of symptoms (chest pain) and
ECG changes of ST segment resolution at 30 minutes after TLT. If
the first thrombolysis was unsuccessful, the remaining half dose
of IV tenecteplase had to be given.
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Results: Successful reperfusion was achieved with tailored
thrombolytic therapy in all patients. Only one patient had rein-
farction on the 3rd day, for which she received another half-dose
Tenectaplase. She remained asymptomatic subsequently. 2 pa-
tients had IV site ecchymosis; no patient had major bleeding. All
the patients had one month follow-up and were asymptomatic.
Conclusion: Tailored thrombolytic therapy in very elderly pa-
tients, many of whom also have high bleeding risk factors, is
effective as well as safe. With the increasing lifespan, the number
of very elderly patients with STEMI is going to increase in the
future, posing a challenge of bleeding risk vs benefit with reper-
fusion strategies; tailored thrombolytic therapy would have
greater relevance in the future and needs to be studied in larger
number of patients.
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Background: Inflammation has been widely acknowledged to
contribute throughout all stages of atherogenesis. At present none
of the anti-cytokine therapy has a specific place in standard
therapeutic regimen for management of CAD. The project aims at
controlling the low grade systemic inflammation in CAD using
Sulfasalazine to improve overall disease outcome.
Methods: 50 eligible subjects (M/F¼43/7) meeting the inclusion/
exclusion criteria for CAD and low grade systemic inflammation,
were randomly assigned to once daily drug (n¼25, mean age¼
57.33±1.52 years) or placebo (n¼25, mean age¼58.58+2.16 years)
tablets (500 mg) for six months along with the previously
continued treatment regimen in all subjects. Assessment was
carried out at baseline, 12 week and subsequently after 24 weeks
of treatment. Various measures like, (a) hsCRP (b) Endothelial-
dependent Flow Mediated dilatation (FMD) of the brachial artery,
(c) Carotid artery IMT and artery stiffness index (Young’ elastic
Modulus), d) Hb, TLC, DLC, SGOT & SGPT, and creatinine were
evaluated. Student’s t-test (p<0.05) was used.
Results: hsCRP declined to (1.12±0.07 vs. 2.40±0.20mg/l, p<0.01),
SBP (118.20±3.11 vs. -128.95±4.19 mmHg, p¼0.04), carotid IMT
(0.68±0.02 vs. 0.79±0.01 mm (p<0.01) and carotid stiffness to 9.73
±0.91 vs. 15.87±3.11 mmHg.mm (p¼0.06) from baseline in drug
group as compared to placebo group, respectively. FMD improved
to 18.31±1.52 vs. 11.72±1.36% in drug group as compared to pla-
cebo group, (p¼0.02), whereas endothelium-independent vasodi-
lation with nitroglycerin (17.76±0.1.27 vs. 17.91± 1.41%; p¼0.94)
remained unchanged in both the groups. Moreover, safety
markers were with-in the normal range in both the groups
(p>0.05).
Conclusions: Thus, it is concluded that Sulfasalazine may act as
novel adjuvant therapeutic approach along with other standard
therapies for the management of CAD due to its effectiveness in
improving the endothelial dysfunction, reducing inflammation
and carotid stiffness.
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Background: Cardiovascular disease is the leading cause of death
worldwide and a majority of these deaths are attributable to
Myocardial infarction. Due paramountcy was given to evaluate
the correlation between the acute phase reactants and the
severity of acute coronary syndrome. One marker which was
under great a deliberation for long was fibrinogen. Albeit thorough
research, the association was debated till recently when many of
the western studies showed a correlation. None of the studies
were done on Indian population.
Objective: To study the correlation between serum fibrinogen
level (SFL) and severity of ACS.
Methods: This is a prospective study on hospitalized patients with
ACS. ACS was diagnosed based on clinical presentation, ECG and
cardiac biomarkers. Blood for fibrinogen was drawn at admission
and was measured by chemiluminescence technique. Coronary
angiography was performed through the femoral artery access
and the angiograms were evaluated by interventional cardiolo-
gists who will be blinded to the study. The severity of ACS was
assessed by Gensini score. Data analysis and interpretation was
done with SPSS 20. The statistical significance of association was
assessed by chi square test and p value of less than 0.05 was
considered significant.
Results: We serially analysed 91 patients presenting with ACS
from February 2014 to April 2014. 29 patients were excluded as per
pre-specified criteria. SFL was plotted against Gensini score in the
remaining 62 patients. Pearson’s correlation coefficient between
SFL and Gensini score was r¼0.869. We have found a significant
correlation between SFL and Gensini score with a significant p
value (<0.05).
Conclusion: Statistically significant correlation exists between SFL
and Gensini score. Higher SFLwere associatedwith higher Gensini
score. We hence conclude to say that serum fibrinogen can be
used to assess the severity of ACS.
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Background: India has a large number of deaths occurring due to
premature CAD, resulting from major risk factors like deranged
lipids. Familial Hypercholesterolemia (FH) is characterized by
isolated high levels of total and LDL cholesterol. It is an autosomal
dominant trait and is highly under recognized entity which if
diagnosed and treated early can prevent deaths due to CAD.
Methods: We enrolled 85 subjects suspected of FH: high total and
LDL cholesterols (>95thcentile), family history of hypercholester-
olemia and premature CAD. Molecular analysis was carried out in
three candidate genes: LDLR, fragment of exon 26 and 29 of ApoB
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